Inflammatory Markers
Inflammatory Markers - Related Videos
12:43
On-Chip Endothelial Inflammatory Phenotyping
0 Views •
Cited by 3 •
2012
Microfluidic flow chambers etched by photolithography and fabricated from PDMS are applied to probe functional outcomes associated with EC dysfunction and inflammation. In a representative experiment, the ability of differential shear stress to modulate monocytic cell adhesion to cytokine activated EC monolayers is demonstrated.
07:22
Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
0 Views •
2025
Here, we present a protocol to assess glycemic control using capillary blood glucose (CBG) and glycated hemoglobin A1C (HbA1C) levels. This study investigates the impact of hyperglycemia on knee osteoarthritis (KOA) symptoms, physical performance, physical activity level, radiographic severity, and inflammation in older adults with diabetes.
01:28
Inflammatory Response
0 Views •
2024
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function. Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
03:45
Quantification of Inflammatory Mediators in Infected Human Tissue-Derived Cells
0 Views •
2025
This video demonstrates the quantification of inflammatory mediators during infection by incubating human lung-tissue-derived immune cells with Haemophilus influenzae. Flow cytometry is used to measure cytokine fluorescence in labeled lymphocytes, correlating with the production of pro-inflammatory cytokines in response to bacterial infection.
12:50
Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
0 Views •
Cited by 1 •
2017
Vascular endothelium tightly controls leukocyte recruitment. Inadequate leukocyte extravasation contributes to human inflammatory diseases. Therefore, searching for novel regulatory elements of endothelial activation is necessary to design improved therapies for inflammatory disorders. Here, we describe a comprehensive methodology to characterize novel endothelial regulators that can modify leukocyte trafficking during inflammation.
FAQs
Inflammatory signals become measurable through a linked local-to-systemic response. After immune cells detect tissue damage or pathogens, interleukins and tumor necrosis factor stimulate local inflammation and may also trigger broader physiological changes. One important downstream effect is hepatic production of C-reactive protein, while inflammation can alter erythrocyte sedimentation, creating laboratory signals of immune activation.
Cytokines, C-reactive protein, and erythrocyte sedimentation represent different points in the response. Interleukins and tumor necrosis factor act as inflammatory mediators that help stimulate local reactions. C-reactive protein reflects a liver-produced downstream response, whereas erythrocyte sedimentation captures a change in blood-cell settling. This distinction separates signaling molecules from indirect laboratory indicators.
An elevated result does not identify a single disease because inflammatory markers can rise in infection, injury, and immune disease, among other clinical circumstances. Their value therefore depends on context rather than on an isolated number. Symptoms, physical examination, and other laboratory findings help clinicians determine whether the measured change fits the suspected inflammatory process.
Clinical assessment may include testing for C-reactive protein, erythrocyte sedimentation rate, cytokines, or other inflammatory markers. Clinicians combine these measurements with symptoms, examination findings, and additional laboratory data rather than interpreting a result alone. This integrated approach supports diagnostic assessment while reducing the risk of treating a nonspecific laboratory change as proof of one condition.
These tests support several clinical tasks rather than a single diagnostic decision. Measurements can contribute to evaluating suspected infection, injury, or immune disease, help assess how active a disease process may be, and provide information for tracking response to treatment. Their role is supportive, so interpretation remains tied to the broader clinical picture.
Measurements over time may help show whether inflammatory activity is changing during treatment. A result that rises or falls should still be considered with symptoms, examination, and other laboratory findings, since these markers are not specific to one cause. This longitudinal use can add evidence about treatment response while complementing, rather than replacing, clinical judgment.